Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are ca ...
Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
The FDA has issued a safety communication regarding the potential for missed alerts with diabetes devices due to software or hardware changes.
FDA published a final version of its guidance document, “Communications From Firms to Health Care Providers Regarding ...
It was not clear from the new administration’s guidance whether the directive will affect more urgent communications, such as foodborne disease outbreaks, drug approvals and new bird flu cases.
The FDA today issued a safety communication relating to certain diabetes devices that connect to smartphones.
US FDA alerts patients of potential to miss critical safety alerts due to phone settings when using smartphone-compatible diabetes devices: Maryland Friday, February 7, 2025, 09:0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results